Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MGNX

Macrogenics Inc

Dec 08 • 04:00PM ET

8.71

Dollar change -0.22
Percentage change -2.46	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	10.92	EPS (ttm)	0.80	Insider Own	5.61%	Shs Outstand	61.70M	Perf Week	3.94%
Market Cap	540.28M	Forward P/E	-	EPS next Y	-1.89	Insider Trans	11.72%	Shs Float	58.55M	Perf Month	26.42%
Income	49.82M	PEG	-	EPS next Q	-0.18	Inst Own	96.83%	Short Float / Ratio	10.99% / 10.75	Perf Quarter	60.70%
Sales	121.13M	P/S	4.46	EPS this Y	119.92%	Inst Trans	-8.61%	Short Interest	6.44M	Perf Half Y	56.65%
Book/sh	3.13	P/B	2.79	EPS next Y	-586.62%	ROA	18.61%	Target Price	12.11	Perf Year	44.21%
Cash/sh	4.13	P/C	2.11	EPS next 5Y	-	ROE	31.44%	52W Range	4.29 - 9.00	Perf YTD	29.81%
Dividend	-	P/FCF	-	EPS past 5Y	-29.27%	ROI	22.22%	52W High	-3.22%	Beta	2.01
Dividend %	-	Quick Ratio	5.66	Sales past 5Y	15.66%	Gross Margin	82.81%	52W Low	103.03%	ATR	0.44
Employees	357	Current Ratio	5.68	Sales Q/Q	-75.09%	Oper. Margin	-88.26%	RSI (14)	74.92	Volatility	4.62% 6.18%
Optionable	Yes	Debt/Eq	0.18	EPS Q/Q	169.85%	Profit Margin	41.13%	Rel Volume	0.63	Prev Close	8.93
Shortable	Yes	LT Debt/Eq	0.16	Earnings	Nov 06 AMC	Payout	-	Avg Volume	598.57K	Price	8.71
Recom	1.50	SMA20	14.61%	SMA50	43.23%	SMA200	49.69%	Volume	379,278	Change	-2.46%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-07-23	Upgrade	Guggenheim	Neutral → Buy	$12
Mar-17-23	Downgrade	Guggenheim	Buy → Neutral
Nov-22-22	Downgrade	Cowen	Outperform → Market Perform
Nov-14-22	Upgrade	BMO Capital Markets	Market Perform → Outperform	$5.70 → $16
Jul-18-22	Downgrade	SMBC Nikko	Outperform → Neutral	$5
Jul-11-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$31 → $4
May-04-22	Downgrade	Guggenheim	Buy → Neutral
Feb-28-22	Upgrade	Citigroup	Neutral → Buy	$23 → $21
Feb-11-22	Initiated	BMO Capital Markets	Outperform	$31
Feb-04-22	Initiated	SMBC Nikko	Outperform	$40
Nov-17-21	Resumed	Guggenheim	Buy	$30
Oct-19-21	Initiated	JMP Securities	Mkt Outperform	$39
Oct-15-21	Resumed	BTIG Research	Buy	$50
Apr-26-21	Resumed	Credit Suisse	Outperform	$37
Mar-12-21	Upgrade	Barclays	Underweight → Overweight	$14 → $40
Dec-22-20	Resumed	H.C. Wainwright	Buy	$36
Aug-03-20	Downgrade	Citigroup	Buy → Neutral	$25 → $26
Jun-01-20	Upgrade	Guggenheim	Neutral → Buy
May-26-20	Reiterated	H.C. Wainwright	Buy	$22 → $40
Mar-04-20	Initiated	Barclays	Underweight	$8

Show Previous Ratings

Nov-07-23 10:56AM	Q3 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents) +17.10%
08:59AM	MacroGenics, Inc. (NASDAQ:MGNX) Q3 2023 Earnings Call Transcript (Insider Monkey)
01:15AM	MacroGenics (MGNX) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-06-23 05:12PM	Macrogenics Inc (MGNX) Reports Q3 2023 Earnings: Net Income of $17. ... (GuruFocus.com)
04:27PM	MacroGenics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Loading…
04:01PM	MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-31-23 04:30PM	MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Sep-05-23 07:00AM	MacroGenics Announces Achievement of $15 Million Milestone Related to Gileads Nomination of a Bispecific Research Program (GlobeNewswire)
Aug-31-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-19-23 07:40AM	3 Under-the-Radar Biotech Stocks to Buy in 2023 (Motley Fool)
Aug-14-23 11:19AM	MacroGenics' (MGNX) Shares Jump 19% in One Week: Here's Why (Zacks) -6.24%
Aug-11-23 01:26PM	MacroGenics, Inc. (NASDAQ:MGNX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 12:33PM	Why Shares of MacroGenics Are Jumping Thursday (Motley Fool) +24.30%
07:01AM	Q2 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents)
11:30PM	Loading…
Aug-09-23 11:30PM	MacroGenics (MGNX) Q2 2023 Earnings Call Transcript (Motley Fool)
05:50PM	MacroGenics (MGNX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:52PM	MacroGenics: Q2 Earnings Snapshot (AP Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 05:35PM	MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Jul-05-23 11:55AM	MacroGenics (NASDAQ:MGNX) shareholders have endured a 83% loss from investing in the stock three years ago (Simply Wall St.)
Jun-28-23 08:12AM	AdaptHealth Corp. (AHCO) Soars 19.6%: Is Further Upside Left in the Stock? (Zacks)
Jun-08-23 07:27AM	MacroGenics Insider Confidence Rewarded, Stock Hits US$321m Market Cap \ (Simply Wall St.)
May-14-23 08:09AM	These Analysts Just Made An Incredible Downgrade To Their MacroGenics, Inc. (NASDAQ:MGNX) EPS Forecasts (Simply Wall St.)
May-10-23 12:10PM	MacroGenics, Inc. (NASDAQ:MGNX) Q1 2023 Earnings Call Transcript (Insider Monkey)
12:30AM	MacroGenics (MGNX) Q1 2023 Earnings Call Transcript (Motley Fool)
May-09-23 05:25PM	MacroGenics (MGNX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:21PM	MacroGenics: Q1 Earnings Snapshot (AP Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results (GlobeNewswire)
May-05-23 08:27AM	MacroGenics, Inc.'s (NASDAQ:MGNX) Share Price Is Matching Sentiment Around Its Revenues (Simply Wall St.)
04:30PM	Loading…
May-04-23 04:30PM	MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Apr-25-23 10:01AM	MacroGenics (MGNX) to Report Q1 Results: Wall Street Expects Earnings Growth (Zacks)
Apr-24-23 06:15PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-07-23 08:48AM	Here's Why We're Not Too Worried About MacroGenics' (NASDAQ:MGNX) Cash Burn Situation (Simply Wall St.)
Mar-22-23 01:22PM	MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ (retifanlimab-dlwr) (GlobeNewswire) -5.76%
Mar-20-23 06:59PM	Why MacroGenics Stock Inched Higher on Monday (Motley Fool)
Mar-18-23 02:52AM	MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-17-23 06:15PM	Why MacroGenics Stock Tumbled Today (Motley Fool)
Mar-16-23 12:17PM	Why Shares of MacroGenics Climbed Thursday (Motley Fool) +10.25%
07:10AM	Q4 2022 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-23 11:00PM	MacroGenics (MGNX) Q4 2022 Earnings Call Transcript (Motley Fool)
05:35PM	MacroGenics (MGNX) Surpasses Q4 Earnings Estimates (Zacks)
04:01PM	MacroGenics Provides Corporate Update and 2022 Financial Results (GlobeNewswire)
Mar-14-23 12:32PM	Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi (Zacks) +9.69%
08:00AM	Synaffix Announces Expansion of ADC Collaboration with MacroGenics (PR Newswire)
Mar-11-23 07:30AM	Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher (Simply Wall St.)
Mar-09-23 03:59PM	Why Shares of MacroGenics Jumped Thursday (Motley Fool) +12.18%
Mar-08-23 05:36PM	MacroGenics Announces Sale of TZIELD Royalty Interest for up to $200 Million (GlobeNewswire) -6.30%
Mar-07-23 06:00PM	MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call (GlobeNewswire)
Mar-02-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-20-23 09:56AM	Strength Seen in MacroGenics (MGNX): Can Its 25.7% Jump Turn into More Strength? (Zacks)
Feb-17-23 06:27AM	Daily Vickers Top Buyers & Sellers for 02/17/2023 (Argus Research) +25.67%
Feb-14-23 10:01AM	MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients (Benzinga) -17.48%
Feb-13-23 05:20PM	MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium (GlobeNewswire) +15.25%
Feb-06-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-24-23 07:57AM	SurModics (SRDX) Surges 6.1%: Is This an Indication of Further Gains? (Zacks) +6.13%
06:48AM	Daily Vickers Top Buyers & Sellers for 01/24/2023 (Argus Research)
Jan-06-23 06:15PM	MacroGenics (MGNX) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-04-23 05:50PM	MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
04:30PM	MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors (GlobeNewswire)
Jan-02-23 09:57AM	Investors in MacroGenics (NASDAQ:MGNX) from five years ago are still down 66%, even after 13% gain this past week (Simply Wall St.)
Dec-29-22 06:51AM	Daily Vickers Top Buyers & Sellers for 12/29/2022 (Argus Research) +14.24%
Dec-06-22 08:01AM	MacroGenics, Inc. (NASDAQ:MGNX) insider upped their holding by 26% earlier this year (Simply Wall St.)
04:48AM	Zacks.com featured highlights MacroGenics, NerdWallet and Euronav (Zacks)
Dec-05-22 09:55AM	Can MacroGenics (MGNX) Climb 74% to Reach the Level Wall Street Analysts Expect? (Zacks) -7.54%
Dec-02-22 09:35AM	MacroGenics (MGNX) Recently Broke Out Above the 20-Day Moving Average (Zacks)
Nov-29-22 12:57PM	Here's How to Find Cheap Stocks Under $10 to Buy for December (Zacks) +6.16%
Nov-22-22 11:55AM	Why Shares of MacroGenics Were Dropping Tuesday (Motley Fool)
Nov-18-22 02:54PM	Rockvilles MacroGenics scores $60M from Provention Bios FDA approval (American City Business Journals)
10:15AM	Provention (PRVB) Gets FDA Nod for Drug That Delays T1D Onset (Zacks)
08:39AM	Zacks.com featured highlights MacroGenics, Olink Holding, NerdWallet, LiveRamp and LivePerson (Zacks)
Nov-17-22 06:10PM	MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab (GlobeNewswire)
09:55AM	Wall Street Analysts Believe MacroGenics (MGNX) Could Rally 123%: Here's is How to Trade (Zacks)
Nov-14-22 06:31PM	Why MacroGenics Stock Crushed the Market on Monday (Motley Fool)
Nov-09-22 05:31AM	MacroGenics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-07-22 06:40PM	Why MacroGenics Stock Popped Again Today (Motley Fool) +8.45%
03:02PM	Rockville's MacroGenics has restructured and inked a major partnership. Here's what comes next. (American City Business Journals)
Nov-04-22 06:51PM	Why MacroGenics Stock Blasted Higher Today (Motley Fool) +22.31%
Nov-03-22 11:30PM	MacroGenics (MGNX) Q3 2022 Earnings Call Transcript (Motley Fool)
06:05PM	MacroGenics (MGNX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	MacroGenics Provides Corporate Update and Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-02-22 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.37%
Nov-01-22 09:55AM	Wall Street Analysts See a 279% Upside in MacroGenics (MGNX): Can the Stock Really Move This High? (Zacks)
Oct-26-22 04:30PM	MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call (GlobeNewswire) -6.67%
10:01AM	Analysts Estimate Zimmer Biomet (ZBH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-25-22 10:01AM	MacroGenics (MGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks) +12.50%
08:29AM	Industry Analysts Just Upgraded Their MacroGenics, Inc. (NASDAQ:MGNX) Revenue Forecasts By 10% (Simply Wall St.)
Oct-18-22 12:44PM	Gilead's (GILD) Yescarta Gets EC Nod for New Cancer Indication (Zacks)
Oct-17-22 01:04PM	MacroGenics strikes deal with Gilead potentially worth more than $1.7B (American City Business Journals) +12.50%
09:15AM	MacroGenics Shares Jump On Gilead Licensing Pact For Blood Cancer Candidates (Benzinga)
07:30AM	Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies (Business Wire)
Oct-10-22 03:37PM	We're A Little Worried About MacroGenics' (NASDAQ:MGNX) Cash Burn Rate (Simply Wall St.)
Sep-12-22 07:14PM	Why MacroGenics Stock Sank Today (Motley Fool) -8.25%
Sep-02-22 07:00AM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-14-22 08:07AM	Brokers Are Upgrading Their Views On MacroGenics, Inc. (NASDAQ:MGNX) With These New Forecasts (Simply Wall St.)
Aug-12-22 09:55AM	Wall Street Analysts Predict a 291% Upside in MacroGenics (MGNX): Here's What You Should Know (Zacks)
Aug-09-22 03:23PM	MacroGenics Jumps Biotech Layoff Bandwagon, Cuts 15% Of Workforce (Benzinga) +12.09%
12:30AM	MacroGenics (MGNX) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-08-22 05:25PM	MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	MacroGenics Provides Update on Corporate Progress and Second Quarter 2022 Financial Results (GlobeNewswire)

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BIOTECH TARGET N V	10% Owner	Oct 02	Buy	4.46	150,000	669,585	9,929,963	Oct 04 03:31 PM
BIOTECH TARGET N V	10% Owner	Sep 07	Buy	5.26	200,000	1,052,840	9,779,963	Sep 11 03:39 PM
HURWITZ EDWARD	Director	Aug 30	Buy	4.91	15,000	73,650	33,074	Sep 01 04:06 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Mar 10	Sale	6.03	5,372	32,393	0	Mar 14 04:22 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 22	Option Exercise	0.00	8,750	0	8,750	Feb 24 04:35 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 22	Option Exercise	0.00	9,375	0	123,799	Feb 24 04:34 PM
BIOTECH TARGET N V	10% Owner	Feb 14	Buy	5.07	500,000	2,532,600	9,579,963	Feb 16 12:37 PM
BIOTECH TARGET N V	10% Owner	Jan 19	Buy	5.30	150,000	794,925	9,079,963	Jan 23 04:21 PM
BIOTECH TARGET N V	10% Owner	Dec 27	Buy	5.61	200,000	1,121,800	8,929,963	Dec 28 11:03 AM
BIOTECH TARGET N V	10% Owner	Dec 23	Buy	5.88	200,000	1,176,800	8,729,963	Dec 28 11:03 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MGNX

Macrogenics Inc

Upgrade your FINVIZ experience